EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
94 hedge funds and large institutions have $207M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 34 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 34
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
94
Holding in Top 10
2
Calls
$3.56M
Puts
$1.25M
Top Buyers
| 1 | +$4.68M | |
| 2 | +$1.2M | |
| 3 | +$946K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$876K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$793K |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$1.45M | |
| 3 | -$963K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$775K |
| 5 |
Squarepoint
New York
|
-$681K |